Physician

Babar Parvez, M.D.

According to 2025 Medicare claims, Babar Parvez, M.D. (NPI: 1346404076) practices cardiac electrophysiology in the Appleton, WI market, with the plurality of this provider's patient population coming from Outagamie, WI. This provider's primary affiliated billing organization is THEDACARE, INCORPORATED (NPI: 1376656959; TIN: 391509362) and primary practice location at 54911-3454. Parvez is affiliated with the THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Parvez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,486 traditional Medicare patients, billed 4,770 HCPCS/CPT codes, and received $103,823 in Medicare payments. The top billing code was 93228 (Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional). Part D data shows 1,140 prescription claims across 266 beneficiaries totaling $396,491 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $43. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $671 to $396,491. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$54K$108K2019 Medicare payment: $32,680 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,542 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $107,572 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $103,124 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $94,321 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $103,823 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191,2441,770$32,680
20202,7594,975$92,542
20212,9165,056$107,572
20222,8334,789$103,124
20232,8104,949$94,321
20242,4864,770$103,823

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$231K$462K2015 Drug cost: $671 (USD; Tot_Drug_Cst)2016 Drug cost: $1,793 (USD; Tot_Drug_Cst)2019 Drug cost: $10,864 (USD; Tot_Drug_Cst)2020 Drug cost: $127,970 (USD; Tot_Drug_Cst)2021 Drug cost: $214,422 (USD; Tot_Drug_Cst)2022 Drug cost: $355,509 (USD; Tot_Drug_Cst)2023 Drug cost: $462,322 (USD; Tot_Drug_Cst)2024 Drug cost: $396,491 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151627$671
2016N/R16$1,793
2017N/RN/RN/R
2018N/RN/RN/R
20193987$10,864
2020129579$127,970
2021180879$214,422
20222161,180$355,509
20232561,352$462,322
20242661,140$396,491

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93228Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional175179$17
93296Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days198584$13
93227Electrocardiogram (ecg) 2-day continuous with review by health care professional240244$12
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report259296$9
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only1,8862,221$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban27715,723$298,022
XareltoRivaroxaban423,435$62,412
Flecainide AcetateFlecainide Acetate24115,330$9,512
DofetilideDofetilide211,290$6,435
Metoprolol SuccinateMetoprolol Succinate15612,490$2,099

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$43Biosense Webster, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Babar Parvez, M.D.?

Tedicare shows public-source Medicare data for Babar Parvez, M.D. (NPI 1346404076), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Babar Parvez, M.D. have ACO affiliation data?

Babar Parvez, M.D. is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Babar Parvez, M.D.?

Babar Parvez, M.D. is linked to THEDACARE, INCORPORATED (billing NPI 1376656959) in the available physician profile data.

Does Babar Parvez, M.D. have Open Payments data?

Babar Parvez, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.